1. Home
  2. TRDA vs ELVA Comparison

TRDA vs ELVA Comparison

Compare TRDA & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$4.65

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

N/A

Current Price

$3.73

Market Cap

328.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TRDA
ELVA
Founded
2016
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
328.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TRDA
ELVA
Price
$4.65
$3.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
★ $17.75
$13.60
AVG Volume (30 Days)
★ 449.9K
395.2K
Earning Date
11-05-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $25,421,000.00
N/A
Revenue This Year
N/A
$10.18
Revenue Next Year
$361.69
$32.63
P/E Ratio
★ N/A
$78.51
Revenue Growth
N/A
★ N/A
52 Week Low
$4.11
$3.68
52 Week High
$16.45
$12.78

Technical Indicators

Market Signals
Indicator
TRDA
ELVA
Relative Strength Index (RSI) 44.20 28.60
Support Level $4.18 N/A
Resistance Level $5.13 $6.85
Average True Range (ATR) 0.51 0.39
MACD 0.05 -0.10
Stochastic Oscillator 23.15 1.82

Price Performance

Historical Comparison
TRDA
ELVA

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

Share on Social Networks: